Search Tufts Medicine

Displaying 61 - 80 of 170
Articles
January 23, 2022
A physician with a special name shares her family history and her passion for medicine.
clinical trial
...

The primary goal of this study is to use the WHOOP fitness band as a way to measure heart rate variability (HRV) in patients with coronary artery disease (CAD) and to establish a change in HRV before coronary artery bypass graft (CABG) surgery and during post-operative stay. The secondary aim of this study would be to associate this change in HRV with the patient’s clinical course. The validation component will test WHOOP’s HRV capabilities compared to the gold-standard Holter monitor. 
Articles
July 7, 2022
Lowell General Hospital has received the American Heart Association’s Get With The Guidelines® - Stroke quality achievement award at both the Main and Saints campuses for our commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines, ultimately leading to more lives saved and reduced disability. The Main campus received Gold Plus status, while the Saints campus achieved Silver Plus status.
Patient Stories
January 27, 2019
I am a family member of a Tufts Medical Center patient. My husband was brought to Tufts as a result of his declining health due to heart failure. The care he received at Tufts MC enabled him to recover from a serious, and at times critical, condition to a point that he is able to have a good quality of life as he awaits a heart transplant.
Announcements
July 27, 2022
The new high-tech CSICU opened Wednesday, May 11 to address a significant shortage of adult critical care capacity.
clinical trial
...

This is a Prospective, multi‐center, international, randomized controlled, post‐market trial.
Articles
January 1, 2020
Smoking. Diabetes. High cholesterol and blood pressure. Not only do they increase your chance of developing heart disease, but of peripheral artery disease, a painful condition of the legs and feet. Fortunately, researchers are working on new treatments.
Announcements
March 15, 2022
For most of her life, Elizabeth Craioveanu, from Hooksett, NH, couldn’t remember ever feeling well for any extended period of time.
Articles
July 20, 2022
High temperatures are expected to continue through the weekend, and we urge everyone to stay safe and avoid heat-related illnesses like dehydration, heat exhaustion and heat stroke by seeking shelter in air conditioning and limiting sun exposure and outside activity.
clinical trial
...

Severe skeletal muscle loss (wasting) and catabolic weight loss are highly common among patients with heart failure with reduced ejection fraction (HFrEF). This prospective randomized controlled trial will compare changes in the muscle mass in the arms and the legs (appendicular lean mass) in patients with HFrEF randomized between 3 groups of no, low or high dose protien supplementation. The dietary protein supplementation will be Ensure(R) products manufactured by Abbott Nutrition.
Patient Stories
November 2, 2020
At 5-foot-8 and 295 pounds, Scott Strainge knew his weight was a contributing factor to his health issues. He was diagnosed with Type 2 diabetes eight years ago, which eventually progressed to a point where he needed seven different medications a day to keep his blood sugar and blood pressure under control.
Announcements
April 28, 2021
Congratulations to the Cardiac Cath Lab team for being featured in an 8-page spotlight article with the nationally popular clinical trade magazine Cath Lab Digest. The article highlights Lowell General Hospital's Heart and Vascular Center facilities, Cath Lab interventions, procedures and protocols, quality measures and offers a glimpse into special protocols and daily challenges faced by the team with the COVID-19 pandemic.
clinical trial
...

This is a Prospective, multicenter, randomized, parallel-controlled, open-label two arm trial with an adaptive design. Eligible subjects will be randomized in a 1:1 ratio to PCI with Impella CP® (Intervention Group) versus standard of care PCI with or without IABP (Control Group). Approximately 1252 subjects will be randomized in a 1:1 ratio to PCI + Impella vs. PCI ± IABP.